← back to search

Federica Armas

National University of Singapore · SG
Area of research
Infectious Diseases · Food Science
Research interest
Research interests include Wastewater, Coronavirus disease 2019 (COVID-19), Pandemic, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Outbreak, and Sewage treatment.
h-index
citations
1,894
works
11
NIH funding
primary concept
email

Recent publications

Metrics to relate COVID-19 wastewater data to clinical testing dynamics
Water Research 2022cited by 119position: middledoi
Making waves: Wastewater surveillance of SARS-CoV-2 in an endemic future
Water Research 2022cited by 81position: middledoi
Rapid displacement of SARS-CoV-2 variant Delta by Omicron revealed by allele-specific PCR in wastewater
Water Research 2022cited by 40position: middledoi
Contextualizing Wastewater-Based surveillance in the COVID-19 vaccination era
Environment International 2022cited by 33position: firstdoi
SARS-CoV-2 RNA concentrations in wastewater foreshadow dynamics and clinical presentation of new COVID-19 cases
The Science of The Total Environment 2021cited by 302position: middledoi
Wastewater surveillance of SARS-CoV-2 across 40 U.S. states from February to June 2020
Water Research 2021cited by 179position: middledoi
Quantitative SARS-CoV-2 Alpha Variant B.1.1.7 Tracking in Wastewater by Allele-Specific RT-qPCR
Environmental Science & Technology Letters 2021cited by 87position: middledoi
Gut Ruminococcaceae levels at baseline correlate with risk of antibiotic-associated diarrhea
iScience 2021cited by 74position: middledoi
Persistence of Dengue (Serotypes 2 and 3), Zika, Yellow Fever, and Murine Hepatitis Virus RNA in Untreated Wastewater
Environmental Science & Technology Letters 2021cited by 53position: middledoi
SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases
mSystems 2020cited by 875position: middledoi
Peptide Inhibitors of Bacterial Protein Synthesis with Broad Spectrum and SbmA-Independent Bactericidal Activity against Clinical Pathogens
Journal of Medicinal Chemistry 2020cited by 51position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Eric J. Alm · Amgen (United States)9 papers (2020–2022)Wei Lin Lee · National University of Singapore9 papers (2020–2022)Xiaoqiong Gu · National University of Singapore9 papers (2020–2022)Janelle R. Thompson · Massachusetts Institute of Technology9 papers (2020–2022)Franciscus Chandra · University of California, Los Angeles7 papers (2021–2022)Hongjie Chen · University of North Carolina at Chapel Hill7 papers (2021–2022)Amy Xiao · Boston University7 papers (2020–2022)Fuqing Wu · Massachusetts Institute of Technology6 papers (2020–2022)Mats Leifels · Nanyang Technological University5 papers (2021–2022)Claire Duvallet · Massachusetts Institute of Technology4 papers (2020–2022)Mariana Matus · Massachusetts Institute of Technology4 papers (2020–2022)Katya Moniz · Massachusetts Institute of Technology4 papers (2020–2022)Stefan Wuertz · National University of Singapore4 papers (2021–2022) · 4 papers (2020–2022) · 3 papers (2021–2022)Timothy B. Erickson · University of Illinois Chicago3 papers (2020–2022)William P. Hanage · Harvard University3 papers (2020–2022)Noriko Endo · Massachusetts Institute of Technology3 papers (2020–2022) · 3 papers (2021–2022)Jianbo Zhang · Massachusetts Institute of Technology3 papers (2020–2022)